Waxman widens Pentagon probe

Bogardus, Kevin
May 2007
Hill;5/11/2007, Vol. 14 Issue 56, p12
The article reports issues that Chairman Henry A. Waxman of the House Oversight and Government Reform Committee may include a massive military contract, plagued by rising cost estimates and design problems, in his wider investigation of federal contracting abuse at the headquarters of the U.S. Department of Defense. The report noted that Waxman asked Defense Secretary Robert Gates for documents related to the Expeditionary Fighting Vehicle (EFV), an amphibious assault vehicle for the Marines.


Related Articles

  • Accountability in Contracting Act Breezes Through Congress.  // Government Procurement;Apr2007, Vol. 15 Issue 2, p8 

    The article reports on the passage of the Accountability in Contracting Act by the House as part of the fiscal year (FY) 2007 emergency appropriations supplemental bill and again as standalone legislation in the U.S. House Committee on Oversight and Government Reform Chairman Henry Waxman...

  • The Few, the Proud, the Savvy. Barry, John; Thomas, Evan // Newsweek;4/20/2009, Vol. 153 Issue 16, p6 

    This article discusses the budget proposals developed by U.S. Defense Secretary Robert Gates. While Gates recommends reductions of investment in military technologies such as the U.S. Air Force F-22 fighter jet and the U.S. Navy DDG 1000 destroyer, he did not recommend the elimination of the...

  • DROP IN FUTURE DEFENSE SPENDING. Kreisher, Otto // Naval Forces;2011, Vol. 32 Issue 1, p10 

    The article focuses on the announcement from Defense Secretary Robert Gates on the reduction of the annual defense spending due to the increasing national budget deficit in the U.S. It notes that the U.S. Army was expected to lessen a total of 69,000 soldiers that it has added since the...

  • Trimming the Pentagon Budget.  // FCNL Washington Newsletter;Sep/Oct2010, Issue 744, p2 

    The article discusses the proposal by U.S. Secretary of Defense Robert Gates to control the spending of the U.S. Department of Defense. It states that the proposal, which is aimed at saving around 100 billion U.S. dollars in the spending of Pentagon over five years, includes some reductions,...

  • Waxman: BlackwaterUSA may have violated tax laws. Flaherty, Anne // Buffalo Law Journal;10/29/2007, Vol. 79 Issue 87, p16 

    The article reports that U.S. Representative Henry Waxman, chairman of the Committee on Oversight and Government Reform, has said that Blackwater USA have violated tax laws and may have defrauded the U.S. government of revenues. Waxman released a March 2007 letter from the Internal Revenue...

  • Part D, Part B Or Part Z, It's About Price Control. Thiel, Karl // BioWorld Today;10/22/2007, Vol. 18 Issue 205, p4 

    The article focuses on a report from the U.S. House Committee on Oversight and Government Reform, at the request of committee Chairman Representative Henry Waxman. The report makes the case that the private-public partnership of Medicare Part D, the prescription drug benefit enacted during...

  • Congressional Democrats taking aim squarely at pre-emption. McCarty, Mark // Medical Device Daily;5/15/2008, Vol. 12 Issue 94, p1 

    The article reports on pre-emption questions surrounding industries regulated by the U.S. Food and Drug Administration (FDA) during the hearing in the House Oversight and Government Reform Committee. Representative Henry Waxman described pre-emption in his opening remarks as a radical doctrine...

  • INSPECTOR WAXMAN'S INQUEST. Brush, Silla; Walsh, Kenneth T. // U.S. News & World Report;2/19/2007, Vol. 142 Issue 6, p24 

    This article reports on the efforts by Democratic Representative Henry Waxman to investigate the use and misuse of government funds, with a focus on the Iraq War. As chairman of the House Oversight and Government Reform Committee, Waxman has subpoena power and a history of thorough, tough and...

  • FDA issues guidance on journal article distribution. M. A. // Medical Marketing & Media;Mar2008, Vol. 43 Issue 3, p8 

    The article reports on the issuance of a draft guidance on "good reprint practice" journal by U.S. Food and Drug Administration (FDA). A 60-day public comment period will precede finalization of the guidance, which aims to clarify between legitimate distribution of journal article and off-label...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics